| MR编号 | SI/H/0226/002 |
|---|
| 药品名称 | Teicoplanin AptaPharma 400 mg powder and solvent for solution for injection/infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Powder and solvent for solution for injection/infusion |
|---|
| 上市许可持有人 | Apta Medica Internacional d.o.o.
Likozarjeva Ulica 6
1000 Ljubljana
Slovenia |
|---|
| 参考成员国 - 产品名称 | Slovenia (SI) Teikoplanin AptaPharma 400 mg prašek in vehikel za raztopino za injiciranje ali infundiranje ali za peroralno suspenzijo |
|---|
| 互认成员国 - 产品名称 | - Bulgaria (BG)
Teicoplanin AptaPharma - Cyprus (CY)
Teicoplanin AptaPharma 400 mg powder and solvent for solution for injection/infusion - Czechia (CZ)
Teicoplanin AptaPharma - Romania (RO)
Teicoplanină AptaPharma 400 mg pulbere şi solvent pentru soluţie injectabilă/perfuzabilă sau soluţie orală - Slovakia (SK)
- Malta (MT)
- Croatia (HR)
- Austria (AT)
- Poland (PL)
Teicoplanin AptaPharma - Hungary (HU)
Teicoplanin AptaPharma 400 mg por és oldószer oldatos injekcióhoz/infúzióhoz vagy belsőleges oldathoz
|
|---|
| 许可日期 | 2022/02/03 |
|---|
| 最近更新日期 | 2023/12/12 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|